×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
4basebio: Unlocking the potential of synthetic DNA
biopharma-reporter.com
We believe synthetic DNA presents a viable solution and is rapidly gaining momentum. AskBio, which is now part of Bayer, and Touchlight have...
3 months ago
4basebio to provide synthetic DNA to tier-one pharma firm
Sharecast.com
4basebio confirmed the provision of its synthetic DNA to an unnamed tier-one pharmaceutical company on Wednesday.
3 weeks ago
Cell-free synthetic DNA in mRNA manufacturing
Labiotech.eu
By Ashish Dhir, PhD and Amy Walker, PhD, 4basebio. The pace, efficacy and scalability with which the success of mRNA vaccines against...
9 months ago
4basebio inks significant DNA supply contract
Sharecast.com
4basebio announced a significant contract through a competitive tender process on Friday, to provide research and GMP-grade synthetic DNA...
2 months ago
How mRNA technology is creating affordable, potent vaccine products
biopharma-reporter.com
We took the time to speak with Amy Walker, VP of research, at biotechnology company 4basebio to discuss if synthetic DNA templates represent...
6 months ago
4basebio Full Year 2022 Earnings: Revenues Disappoint
Simply Wall Street
4basebio ( LON:4BB ) Full Year 2022 Results Key Financial Results Net loss: UK£5.15m (loss widened by 59% from FY...
11 months ago
4basebio Full Year 2022 Earnings: Revenues Disappoint
Yahoo News New Zealand
4basebio ( LON:4BB ) Full Year 2022 Results Key Financial Results Net loss: UK£5.15m (loss widened by 59% from FY...
11 months ago
Expedeon AG to rebrand as 4basebio and focus on DNA manufacture after Abcam concludes 120m euro deal
Cambridge Independent
Expedeon AG to rebrand as 4basebio and focus on DNA manufacture after Abcam concludes 120m euro deal ... Expedeon AG is to rebrand as 4basebio as...
51 months ago
4basebio enters research collaboration with eTheRNA
Sharecast.com
Cell and gene therapy intellectual property company 4basebio announced a strategic research collaboration between its wholly-owned...
27 months ago
Abcam acquires gene-editing platform from US biotech Applied StemCell
Cambridge Independent
Abcam is expanding its off-the-shelf offering of edited cell lines with its latest acquisition. The Cambridge Biomedical Campus-based...
50 months ago